Study finds doctor reviews matter to some extent

Share this article:
Study finds doctor reviews matter to some extent
Study finds doctor reviews matter to some extent

A report published by the Journal of the American Medical Association Tuesday shows that the patient-as-consumer perspective touted by the pharmaceutical industry is playing out in doctors' offices.

The findings, distilled from 2,137 patients, found that almost 60% of the participants considered doctor rating sites “somewhat important” when they chose a doctor, even though such sites were rated as secondary to first-hand recommendations from family and friends.

The study did not indicate how social the surveyed sites were, but the perceived impact these sites have on non-medical businesses is such that Googling the terms "negative review" or "negative comments" and "lawsuit" brings up a spate of information about lawsuits over comments.

Researchers found that bad medical reviews kept away 37% of the surveyed patients who used physician-scoring services, while good reviews pulled in 35% of respondents who used review sites.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...